This site is intended for health professionals only

Home / News / Pharmacists alerted after wrong patient information leaflet put into some osteoporosis medicine packs

Pharmacists alerted after wrong patient information leaflet put into some osteoporosis medicine packs


By Beth Kennedy
Editor-in-chief

04 Apr 2019

The Government’s medicines watchdog has called on pharmacists to rectify a problem with the patient information leaflet (PIL) in some packs of Zoledronic acid 5mg solution for infusion.

Some packs of the drug – used to treat bone diseases like osteoporosis – manufactured by Ranbaxy UK mistakenly contain the PIL for Temozolomide 180mg capsules instead of the correct one, the Medicines and Healthcare products Regulatory Agency (MHRA) warned today (4 April).

Pharmacists should check packs of the affected batch contains the right PIL and replace it with the correct one if they find packs that do not, the MHRA said. The correct PIL can be downloaded here.

The affected batch is:

Batch Number Expiry Date Pack Size First Distributed
JKT1576A 30/04/2020 1 x 100ml 12th October 2018

 

Those with any enquiries should contact the Ranbaxy/Sun Pharmaceuticals customer services team on 020 8848 5050 or email Cserv.uk@sunpharma.com


Want news like this straight to your inbox?


Latest News

Regulator was wrong in finding pharmacist’s words were ‘not antisemitic’, High Court says
The High Court has upheld an appeal against a GPhC ruling that comments made by...
PDA condemns satirical ‘attack’ on pharmacist MP
A national newspaper and satirical website have been accused of ‘attacking’ pharmacist and MP for...
booster jab
Pharmacies should lead on Covid booster jabs to free up GPs’ time
Community pharmacies should play a 'significant role' in the Covid booster vaccine delivery plan, pharmacy...